Melanoma May No Longer Be a Death Sentence

Melanoma May No Longer Be a Death Sentence Play

June 3 (Bloomberg) -- The next generation of experimental immune-boosting drugs from Merck, Bristol-Myers and Roche are producing such promising early results that doctors are openly speculating that some patients with the deadliest form of skin cancer may be cured. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

blog comments powered by Disqus